Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Danaher Corp DHR

Technology Scientific & Technical Instruments
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the... see more

Recent & Breaking News (NYSE:DHR)

Danaher Reports First Quarter 2024 Results

PR Newswire 2 days ago

Danaher Schedules First Quarter 2024 Earnings Conference Call

PR Newswire March 21, 2024

Danaher to Present at TD Cowen Health Care Conference

PR Newswire February 27, 2024

Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets

PR Newswire February 22, 2024

Danaher Announces Quarterly Dividend

PR Newswire February 21, 2024

Danaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development

PR Newswire February 5, 2024

Danaher Reports Fourth Quarter and Full Year 2023 Results

PR Newswire January 30, 2024

Danaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform Solution

PR Newswire January 9, 2024

Danaher CEO to Comment on Financial Performance

PR Newswire January 8, 2024

Danaher to Present at J.P. Morgan Healthcare Conference

PR Newswire January 2, 2024

Danaher Schedules Fourth Quarter 2023 Earnings Conference Call

PR Newswire December 21, 2023

Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase

GlobeNewswire December 13, 2023

Danaher Completes Acquisition of Abcam

PR Newswire December 6, 2023

Danaher Announces Quarterly Dividend

PR Newswire December 5, 2023

Danaher to Present at Evercore ISI HealthCONx Conference

PR Newswire November 21, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Danaher Corporation (DHR) Investigation

Accesswire November 17, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Danaher Corporation (DHR) Investigation

Accesswire November 16, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Danaher Corporation (DHR) Investigation

Accesswire November 15, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Danaher Corporation (DHR) Investigation

Accesswire November 14, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Danaher Corporation (DHR) Investigation

Accesswire November 12, 2023